Keyphrases
Risk Reduction
100%
Meta-analysis
100%
Randomized Trial
100%
Hepatocellular Carcinoma
100%
Cirrhosis
44%
Sequential Analysis
22%
I(2)
22%
Subgroup Analysis
11%
Risk Difference
11%
Esophageal Varices
11%
Information Size
11%
Systematic Meta-analysis
11%
Number-needed-to-treat
11%
Sensitivity Analysis
11%
Random-effects Meta-analysis
11%
Regression Analysis
11%
Multiple Testing
11%
Control Risk
11%
Angiogenesis
11%
AIMS™
11%
Manual Search
11%
Fixed Effects
11%
Bacterial Translocation
11%
Electronic Search
11%
Heterogeneity Bias
11%
Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Meta-Analysis
100%
Hepatocellular Carcinoma
100%
Liver Cirrhosis
44%
Sequential Analysis
22%
Numbers Needed to Treat
11%
Esophageal Varices
11%
Angiogenesis
11%
Subgroup Analysis
11%
Bacterial Translocation
11%
Systematic Review with Meta-Analysis
11%
Attributable Risk
11%
Nursing and Health Professions
Beta Adrenergic Receptor Blocking Agent
100%
Liver Cell Carcinoma
100%
Meta Analysis
100%
Liver Cirrhosis
44%
Sequential Analysis
22%
Systematic Review with Meta-Analysis
11%
Numbers Needed to Treat
11%
Attributable Risk
11%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Beta Adrenergic Receptor Blocking Agent
100%
Liver Cirrhosis
44%
Number Needed to Treat
11%
Esophagus Varices
11%